for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-AstraZeneca Says U.S. FDA Accepted Biologics License Application For Potential Treatment In Systemic Lupus Erythematosus

Nov 5 (Reuters) - AstraZeneca PLC:

* ASTRAZENECA- U.S. FDA ACCEPTED BIOLOGICS LICENSE APPLICATION FOR POTENTIAL TREATMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS, A COMPLEX AUTOIMMUNE DISEASE Source text: bit.ly/36aIxx1 Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up